Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-08-25 Sale | 2024-05-09 5:27 pm | Akebia Therapeutics Inc. | AKBA | Burke Steven Keith SVP, Chief Medical Officer | 27,000 | $1.15 | $31,050 | 668,840 (Direct) | View |
| 2024-02-29 Sale | 2024-03-01 5:46 pm | Akebia Therapeutics Inc. | AKBA | Burke Steven Keith SVP, Chief Medical Officer | 7,169 | $1.58 | $11,327 | 695,840 (Direct) | View |
| 2024-02-27 Sale | 2024-02-29 6:01 pm | Akebia Therapeutics Inc. | AKBA | Burke Steven Keith SVP, Chief Medical Officer | 8,367 | $1.52 | $12,718 | 703,009 (Direct) | View |
| 2024-02-01 Sale | 2024-02-02 4:10 pm | Akebia Therapeutics Inc. | AKBA | Burke Steven Keith SVP, Chief Medical Officer | 24,311 | $1.68 | $40,842 | 1,014,676 (Direct) | View |
| 2023-05-16 Sale | 2023-05-18 6:20 pm | Akebia Therapeutics Inc. | AKBA | Burke Steven Keith SVP, Chief Medical Officer | 63,567 | $1.068 | $67,890 | 530,487 (Direct) | View |
| 2023-03-01 Sale | 2023-03-03 08:01 am | Akebia Therapeutics Inc. | AKBA | Burke Steven Keith SVP, Chief Medical Officer | 14,123 | $0.8775 | $12,393 | 594,054 (Direct) | View |
| 2023-02-27 Sale | 2023-03-01 4:06 pm | Akebia Therapeutics Inc. | AKBA | Burke Steven Keith SVP, Chief Medical Officer | 7,539 | $0.8132 | $6,131 | 608,177 (Direct) | View |
| 2022-08-31 Sale | 2022-09-01 4:15 pm | Akebia Therapeutics Inc. | AKBA | Burke Steven Keith SVP, Chief Medical Officer | 1,147 | $0.3625 | $416 | 418,016 (Direct) | View |
| 2022-02-28 Sale | 2022-03-02 9:12 pm | Akebia Therapeutics Inc. | AKBA | Burke Steven Keith SVP, Chief Medical Officer | 15,056 | $2.1629 | $32,564 | 442,663 (Direct) | View |
| 2021-08-31 Sale | 2021-09-02 4:07 pm | Akebia Therapeutics Inc. | AKBA | Burke Steven Keith SVP, Chief Medical Officer | 1,042 | $2.83 | $2,949 | 171,219 (Direct) | View |
| 2021-04-01 Sale | 2021-04-01 8:31 pm | Akebia Therapeutics Inc. | AKBA | Burke Steven Keith SVP, Chief Medical Officer | 1,081 | $3.4 | $3,675 | 170,761 (Direct) | View |
| 2021-03-01 Sale | 2021-03-02 4:06 pm | Akebia Therapeutics Inc. | AKBA | Burke Steven Keith SVP, Chief Medical Officer | 7,558 | $3.3961 | $25,668 | 281,442 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-31 Option Award | 2024-02-02 4:10 pm | N/A 2034-01-31 | Akebia Therapeutics Inc. | AKBA | Burke Steven Keith SVP, Chief Medical Officer | 505,500 | $0 | 1,014,676 (Direct) | View |
| 2023-01-31 Option Award | 2023-02-02 4:14 pm | N/A 2033-01-31 | Akebia Therapeutics Inc. | AKBA | Burke Steven Keith SVP, Chief Medical Officer | 490,500 | $0 | 910,016 (Direct) | View |
| 2022-05-12 Option Award | 2022-05-16 4:08 pm | 2023-05-12 2032-05-12 | Akebia Therapeutics Inc. | AKBA | Burke Steven Keith SVP, Chief Medical Officer | 200,000 | $0 | 617,663 (Direct) | View |
| 2022-02-28 Option Award | 2022-03-02 9:12 pm | N/A 2032-02-28 | Akebia Therapeutics Inc. | AKBA | Burke Steven Keith SVP, Chief Medical Officer | 285,000 | $0 | 442,663 (Direct) | View |
| 2021-03-16 Option Award | 2021-03-18 7:16 pm | N/A N/A | Akebia Therapeutics Inc. | AKBA | Burke Steven Keith SVP, Chief Medical Officer | 10,400 | $0 | 171,842 (Direct) | View |
| 2021-02-26 Option Award | 2021-03-02 4:06 pm | N/A 2031-02-26 | Akebia Therapeutics Inc. | AKBA | Burke Steven Keith SVP, Chief Medical Officer | 190,000 | $0 | 281,442 (Direct) | View |
| 2020-02-28 Option Award | 2020-03-02 7:25 pm | N/A 2030-02-28 | Akebia Therapeutics Inc. | AKBA | Burke Steven Keith SVP, Chief Medical Officer | 167,500 | $0 | 204,500 (Direct) | View |